Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Crofelemer, a novel agent for treatment of secretory diarrhea.

Crutchley RD, Miller J, Garey KW.

Ann Pharmacother. 2010 May;44(5):878-84. doi: 10.1345/aph.1M658. Epub 2010 Apr 13. Review.

PMID:
20388859
2.

Crofelemer, a novel antisecretory agent approved for the treatment of HIV-associated diarrhea.

Yeo QM, Crutchley R, Cottreau J, Tucker A, Garey KW.

Drugs Today (Barc). 2013 Apr;49(4):239-52. doi: 10.1358/dot.2013.49.4.1947253.

PMID:
23616951
3.

Crofelemer for the treatment of secretory diarrhea.

Cottreau J, Tucker A, Crutchley R, Garey KW.

Expert Rev Gastroenterol Hepatol. 2012 Feb;6(1):17-23. doi: 10.1586/egh.11.87. Review.

PMID:
22149578
4.

Efficacy and safety of crofelemer for noninfectious diarrhea in HIV-seropositive individuals (ADVENT trial): a randomized, double-blind, placebo-controlled, two-stage study.

Macarthur RD, Hawkins TN, Brown SJ, Lamarca A, Clay PG, Barrett AC, Bortey E, Paterson C, Golden PL, Forbes WP.

HIV Clin Trials. 2013 Nov-Dec;14(6):261-73. doi: 10.1310/hct1406-261.

PMID:
24334179
5.

Crofelemer: In HIV Associated Diarrhea and Secretory Diarrhea - A Patent Perspective.

Biswal S.

Recent Pat Antiinfect Drug Discov. 2014;9(2):136-43. Review.

PMID:
25851117
6.

Evaluation of crofelemer in the treatment of diarrhea-predominant irritable bowel syndrome patients.

Mangel AW, Chaturvedi P.

Digestion. 2008;78(4):180-6. doi: 10.1159/000185719. Epub 2008 Dec 18.

PMID:
19092244
7.
8.

Crofelemer, a novel agent for treatment of non-infectious diarrhea in HIV-infected persons.

Chordia P, MacArthur RD.

Expert Rev Gastroenterol Hepatol. 2013 Sep;7(7):591-600. doi: 10.1586/17474124.2013.832493. Review.

PMID:
24070150
9.

Crofelemer for the treatment of chronic diarrhea in patients living with HIV/AIDS.

Patel TS, Crutchley RD, Tucker AM, Cottreau J, Garey KW.

HIV AIDS (Auckl). 2013 Jul 15;5:153-62. doi: 10.2147/HIV.S30948. Print 2013.

10.

Crofelemer for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy.

Castro JG, Chin-Beckford N.

Expert Rev Clin Pharmacol. 2015;8(6):683-90. doi: 10.1586/17512433.2015.1082424. Epub 2015 Aug 27. Review.

PMID:
26517110
11.

Crofelemer, an antisecretory antidiarrheal proanthocyanidin oligomer extracted from Croton lechleri, targets two distinct intestinal chloride channels.

Tradtrantip L, Namkung W, Verkman AS.

Mol Pharmacol. 2010 Jan;77(1):69-78. doi: 10.1124/mol.109.061051. Epub 2009 Oct 6.

12.

Dacomitinib-induced diarrhea: Targeting chloride secretion with crofelemer.

Van Sebille YZA, Gibson RJ, Wardill HR, Ball IA, Keefe DMK, Bowen JM.

Int J Cancer. 2018 Jan 15;142(2):369-380. doi: 10.1002/ijc.31048. Epub 2017 Sep 28.

PMID:
28921512
13.

A double blind, randomized, placebo-controlled phase II study to assess the safety and efficacy of orally administered SP-303 for the symptomatic treatment of diarrhea in patients with AIDS.

Holodniy M, Koch J, Mistal M, Schmidt JM, Khandwala A, Pennington JE, Porter SB.

Am J Gastroenterol. 1999 Nov;94(11):3267-73.

PMID:
10566728
14.

Crofelemer (Fulyzaq) for antiretroviral-induced diarrhea.

[No authors listed]

Med Lett Drugs Ther. 2013 Jul 22;55(1421):59-60. No abstract available.

PMID:
23863919
15.

The role of loperamide in gastrointestinal disorders.

Hanauer SB.

Rev Gastroenterol Disord. 2008 Winter;8(1):15-20. Review.

PMID:
18477966
16.

[Controlled clinical testing of an antidiarrheal].

Dorn M.

MMW Fortschr Med. 2004 Aug 5;146 Suppl 2:57-60. German.

PMID:
16739360
17.

A tannic acid-based medical food, Cesinex(®), exhibits broad-spectrum antidiarrheal properties: a mechanistic and clinical study.

Ren A, Zhang W, Thomas HG, Barish A, Berry S, Kiel JS, Naren AP.

Dig Dis Sci. 2012 Jan;57(1):99-108. doi: 10.1007/s10620-011-1821-9. Epub 2011 Jul 12.

18.

Cecectomized rat. A model of experimental secretory diarrhea in conscious animals.

Fondacaro JD, Kolpak DC, Burnham DB, McCafferty GP.

J Pharmacol Methods. 1990 Aug;24(1):59-71.

PMID:
2214801
19.

Systematic review: racecadotril in the treatment of acute diarrhoea in children.

Szajewska H, Ruszczyński M, Chmielewska A, Wieczorek J.

Aliment Pharmacol Ther. 2007 Sep 15;26(6):807-13. Review.

20.

NPY Y2 receptor agonist PYY(3-36) inhibits diarrhea by reducing intestinal fluid secretion and slowing colonic transit in mice.

Moriya R, Shirakura T, Hirose H, Kanno T, Suzuki J, Kanatani A.

Peptides. 2010 Apr;31(4):671-5. doi: 10.1016/j.peptides.2009.11.005. Epub 2009 Nov 17.

PMID:
19925840

Supplemental Content

Support Center